Fuld

NOVEMBER 1, 2022

In this role, Brad will advise our teams and clients from the Health and Life Sciences industries, and promote our portfolio of solutions, including market and business research, competitive intelligence, thought leadership, data analytics, strategic insights, and shared services. About Fuld & Company. www.fuld.com.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

Alpha Sense BI

AUGUST 30, 2023

As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Now integrated into nearly every industry, genAI is fast becoming a must-have for any firm that aims to get the competitive edge.

Management 98

Management Biotech Due Diligence Algorithm 98

Alpha Sense BI

MAY 5, 2023

2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech.

Biotech 97

Biotech Capital Banking Startups 97

Evalueserve

DECEMBER 6, 2021

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. These companies will be able to reshape the competitive landscape of the pharmaceutical industry.

Capital 98

Capital Globalization Biotech Marketing 98

CIO

DECEMBER 27, 2023

These countries offer competitive salaries, a lower cost of living compared to other major tech hubs, and better opportunities for quality of life and work-life balance. A survey from global talent marketplace Andela found that 88% of enterprise companies are looking for top tech talent in other countries.

Startups 860

Startups Biotech Capital Innovation 860

Alpha Sense BI

APRIL 29, 2024

Market Analysis : A valuable tool for conducting market research , as it can analyze large volumes of market data, predict market trends, analyze customer preferences, and provide a snapshot of the competitive landscape. Competition for fundraising will continue heating up among startup companies in 2024.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

APRIL 19, 2024

2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e. OpenAI’s ChatGPT ). Having proven to be a catalyst for business growth, genAI is projected to boast a $1.3 Start your free trial today.

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. In the age of information overload, you need reliable resources of insights to act quickly.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

JANUARY 26, 2024

Missling | President, CEO, Secretary & Director of Anavex Life Sciences Staying Ahead of Developments in the Healthcare Industry Scouting out new healthcare investment opportunities before your competition requires a cutting-edge research tool. This renewed interest in rare disease therapeutics can be attributed to the U.S.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

APRIL 12, 2024

Generally, expert calls provide investment researchers with the operator’s perspective, which is critical to understanding competitive moats and enhancing data-driven research with soft data. You think, ‘I have competitively a better methodology, a better framework, and you think the world will go on it.’ It’s one of those things.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. Adi received his B.S. in Applied Mathematics and B.A. Helena Cisneros Sr. He holds B.A.

Retail 52

Retail Capital Finance Biotech 52

CIO

JULY 17, 2023

Many IT leaders today are focused more on security management as well as improving IT operations and systems performance than they are on top-line and strategic activities such as driving business innovation, identifying competitive differentiation opportunities, and even working on business strategy.

Biotech 617

Biotech Innovation Technology Technology 617

Alpha Sense BI

NOVEMBER 9, 2022

Customers have multiyear R&D product road maps, and the competitive environment for customers is more challenging today than it’s ever been. M&A IPOs to watch in Pharma and Biotech. Zaslav, President, CEO & Director. JOYY Inc. [YY]. Earnings: Estimated Thu Nov 10, 2022. Scroll back to top. Exclusive Webcast.

Sales 52

Sales Loss Capital Biotech 52

Alpha Sense BI

MARCH 13, 2024

billion acquisition of Carmot Therapeutics, a clinical-stage biotechnology company with three GLP-1 assets in clinical production, including its CT-388 lead GLP-1 asset, in the hopes of gaining a competitive footing among Novo Nordisk and Eli Lilly’s products currently on the market (Ozempic, Wegovy, and Mounjaro, respectively).

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

Pricing: Learn how the price of Stream by AlphaSense ’s premium expert transcript library can keep you ahead of the competition. Do they have a competitive pricing strategy in place? Try AlphaSense for Free To stay ahead of your competition and be agile in your decision-making, you need expert insights. Who uses expert networks?

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Happy Market

MAY 9, 2022

So that’s the seeing through the windshield, like I spend so much time looking at yesterday’s numbers and last week’s numbers and today’s competitive numbers, am I really looking next week and two months from now and six months from now and three years from now, right?

Management 52

Management Entertainment Market Research Marketing Research 52